Integra LifeSciences Corporation

Integra LifeSciences Corporation is a Healthcare organization associated with the domain integralife.com and based in Plainsboro, New Jersey, United States.

The organization operates in the Medical Devices sector.

Integra LifeSciences Corporation is based in Plainsboro, New Jersey, United States. The organization's identified headquarters or primary location is Plainsboro, New Jersey, United States, based on publicly available organizational information.

Integra LifeSciences Corporation operates in the Medical Devices sector, with its public profile associated with Healthcare.

Its Vendor Intelligence profile is categorized under Medical Devices → Healthcare.

Integra LifeSciences Corporation operates in the Medical Devices sector and is associated with Integra LifeSciences has a broad portfolio of innovative products and solutions used in neurosurgery, wound reconstruction and care, surgical reconstruction, surgical instrumentation and lighting, and ear, nose and throat..

Its public digital presence and organizational information provide additional context about its products, services, capabilities and market positioning.

The official website associated with Integra LifeSciences Corporation is integralife.com. OrgIntel360 uses the organization's identified domain as an important reference point when evaluating its public vendor identity, digital presence and third-party profile.

Integra LifeSciences Corporation is indexed in VendorIntel360 as a vendor, supplier or technology organisation associated with integralife.com. The public profile covers vendor identity, relationship context, supply-chain signals and monitoring indicators from observable sources.

Vendor relationships can vary by evidence, tier and time, so individual signals should be considered within their broader context.

VendorIntel360 maps third-party and customer relationships for Integra LifeSciences Corporation only when verified relationship evidence is stored. A CDN, SaaS pixel, library observation or similar technology fingerprint is not treated as a contractual vendor link.

Current relationship status: No significant signals identified on the public preview. Monitoring continues.

Vendor identity for Integra LifeSciences Corporation includes its legal or trading name, official domain, industry context, location and other publicly indexed organisational details. OrgIntel360 uses these elements as the starting point for third-party due diligence and monitoring.

Integra LifeSciences Corporation can be reviewed as a supplier, partner or technology vendor in procurement, TPRM and supply-chain assessments. VendorIntel360 provides an outside-in identity and relationship frame that can sit alongside questionnaires, contracts and internal controls.

Vendor monitoring for Integra LifeSciences Corporation can include public identity changes, relationship evidence, concentration signals, fourth-party exposure and related risk indicators associated with integralife.com. Monitoring continues on the public preview even when no significant signal is currently listed.

Fourth-party exposure sits behind a primary supplier. VendorIntel360 surfaces downstream vendors associated with Integra LifeSciences Corporation only when supporting evidence exists — absence of a listed fourth party is not proof that none exist.

Current fourth-party status: No significant signals identified on the public preview. Monitoring continues.

Concentration risk is the over-reliance that can arise when too much of a process, region or technology stack depends on Integra LifeSciences Corporation or a small vendor set. OrgIntel360 highlights concentration signals when evidence is available, rather than inferring them from a single public mention.

Dependency signals for Integra LifeSciences Corporation may include verified vendor edges, disclosed partners and other supported graph relationships. Stack fingerprints and marketing claims are not used as proof of a supplier contract on this public page.

A verified vendor relationship requires recorded evidence such as a disclosed partner, a supported graph edge or another stored relationship — not a banner ad, job post or HTML comment. Until that evidence exists, Integra LifeSciences Corporation is indexed as an organisation you may assess, not as a confirmed node in a specific supply chain.

Relevant vendor exposure may include identity changes, new or lapsed relationship evidence, fourth-party signals, concentration indicators and related risk context around integralife.com. Monitoring these areas can help identify emerging third-party and supply-chain risk.

A Vendor Intelligence profile can support the decision by providing context about Integra LifeSciences Corporation's identity, vendor posture, relationship evidence, supply-chain signals and potential third-party risks. Whether to engage should ultimately depend on the organization's requirements, risk appetite, commercial considerations and broader due-diligence findings.

Before engaging with Integra LifeSciences Corporation, decision-makers should verify the organization's identity, official domain, vendor profile, relevant relationship evidence, public information, potential concentration or fourth-party signals and any additional requirements specific to the proposed relationship.

Potential third-party risk depends on the nature of the relationship, the organization's risk requirements and the current evidence available about Integra LifeSciences Corporation. OrgIntel360 provides vendor, relationship, supply-chain and related signals that can help decision-makers identify areas requiring further review.

The need for additional due diligence depends on the proposed relationship, risk appetite, industry requirements and available intelligence. OrgIntel360 can help identify vendor, concentration, fourth-party and other signals that may indicate areas requiring additional investigation.

Decision-makers can use the Vendor Intelligence profile to understand Integra LifeSciences Corporation's organizational identity, vendor posture, relationship context, supply-chain signals and relevant third-party risk indicators. These insights can provide additional context for procurement, TPRM, partnership, investment and other business decisions.